IDD-Xpert

IDD-Xpert

Lyon, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2013 and headquartered in Lyon, France, with a GMP manufacturing facility in Evreux, IDD-Xpert operates as a specialized Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO). It serves over 300 international customers, focusing on innovative drug delivery for small molecules and biologics, with a strong emphasis on powder-based formulations like tablets and inhaled products (pMDIs, sprays). The company's business model is entirely service-based, generating revenue through its R&D platform and manufacturing services for pharmaceutical and cosmetic clients.

Drug Delivery

Technology Platform

Integrated R&D platform specializing in powder characterization, QbD formulation, process scale-up, and GMP manufacturing for oral and inhaled dosage forms. Combines analytical development, stability testing, and regulatory support.

Opportunities

The growing outsourcing trend in pharma R&D and the increasing complexity of new drug molecules (especially biologics) create strong demand for specialized formulation expertise.
The niche focus on inhaled and powder-based formulations addresses a high-value, technically challenging segment with significant barriers to entry.

Risk Factors

Revenue is project-based and susceptible to fluctuations in client R&D budgets.
The company faces intense competition from larger global CDMOs and other niche players.
Operational risks include maintaining strict GMP compliance and retaining key scientific talent in a competitive market.

Competitive Landscape

IDD-Xpert competes in the fragmented CDMO/CRO market, facing competition from large global players (e.g., Lonza, Catalent) with broader offerings and other specialized European CDMOs focused on formulation. Its differentiation lies in its deep, integrated expertise in powder science and inhaled/oral dosage forms for both pharma and cosmetics.